View in EDS HTML Full Text PDF Full Text

Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.

Saved in:
Bibliographic Details
Title: Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
Authors: Shimura M; Tokyo Medical University Hachioji Medical Center, 1163, Tatemachi, Hachioji-shi, Tokyo, 193-0998, Japan. masahiko@v101.vaio.ne.jp., Kitano S; Tokyo Women's Medical University Hospital, Tokyo, Japan., Ogata N; Nara Medical University Hospital, Nara, Japan., Mitamura Y; Tokushima University Graduate School, Tokushima, Japan., Oh H; Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan., Ochi H; Chugai Pharmaceutical Co., Ltd., Tokyo, Japan., Ohsawa S; Chugai Pharmaceutical Co., Ltd., Tokyo, Japan., Hirakata A; Kyorin University School of Medicine, Tokyo, Japan.
Corporate Authors: YOSEMITE and RHINE Investigators
Source: Japanese journal of ophthalmology [Jpn J Ophthalmol] 2023 May; Vol. 67 (3), pp. 264-279. Date of Electronic Publication: 2023 Mar 10.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Springer Tokyo Country of Publication: Japan NLM ID: 0044652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1613-2246 (Electronic) Linking ISSN: 00215155 NLM ISO Abbreviation: Jpn J Ophthalmol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36897413
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shimura+M%22">Shimura M</searchLink>; Tokyo Medical University Hachioji Medical Center, 1163, Tatemachi, Hachioji-shi, Tokyo, 193-0998, Japan. masahiko@v101.vaio.ne.jp.<br /><searchLink fieldCode="AU" term="%22Kitano+S%22">Kitano S</searchLink>; Tokyo Women's Medical University Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ogata+N%22">Ogata N</searchLink>; Nara Medical University Hospital, Nara, Japan.<br /><searchLink fieldCode="AU" term="%22Mitamura+Y%22">Mitamura Y</searchLink>; Tokushima University Graduate School, Tokushima, Japan.<br /><searchLink fieldCode="AU" term="%22Oh+H%22">Oh H</searchLink>; Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan.<br /><searchLink fieldCode="AU" term="%22Ochi+H%22">Ochi H</searchLink>; Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ohsawa+S%22">Ohsawa S</searchLink>; Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hirakata+A%22">Hirakata A</searchLink>; Kyorin University School of Medicine, Tokyo, Japan.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22YOSEMITE+and+RHINE+Investigators%22">YOSEMITE and RHINE Investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220044652%22">Japanese journal of ophthalmology</searchLink> [Jpn J Ophthalmol] 2023 May; Vol. 67 (3), pp. 264-279. <i>Date of Electronic Publication: </i>2023 Mar 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Tokyo%22">Springer Tokyo </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>0044652 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1613-2246 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200215155%22">00215155 </searchLink><i>NLM ISO Abbreviation: </i>Jpn J Ophthalmol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36897413
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10384-023-00979-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 264
    Titles:
      – TitleFull: Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shimura M
      – PersonEntity:
          Name:
            NameFull: Kitano S
      – PersonEntity:
          Name:
            NameFull: Ogata N
      – PersonEntity:
          Name:
            NameFull: Mitamura Y
      – PersonEntity:
          Name:
            NameFull: Oh H
      – PersonEntity:
          Name:
            NameFull: Ochi H
      – PersonEntity:
          Name:
            NameFull: Ohsawa S
      – PersonEntity:
          Name:
            NameFull: Hirakata A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2023 May
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1613-2246
          Numbering:
            – Type: volume
              Value: 67
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Japanese journal of ophthalmology
              Type: main
ResultId 1